At just four months old, Josephine Gilmore’s life took an unexpected turn when doctors diagnosed her with Spinal Muscular Atrophy (SMA) — a rare genetic condition that affects the body’s ability to move, swallow, and breathe.

For her family, the news was overwhelming.

SMA is one of the most serious genetic conditions affecting infants, and its rarity — occurring in roughly one in 11,000 births — means many families are unaware of it until they are suddenly faced with the diagnosis. Josephine’s mother, Casey Gilmore, recalls the wave of emotions that followed.

“I kept asking myself what I could have done differently,” she shared softly. “You never expect something like this, and suddenly your whole world changes.”

By the time Josephine was six months old, her condition had already progressed significantly. Her parents were told that a large portion of her motor nerve cells had been affected, making every day feel incredibly precious.

But in the middle of uncertainty, a new possibility appeared.

Doctors introduced the family to Zolgensma, a groundbreaking gene therapy designed as a one-time treatment that may help improve the condition. Though the cost of the treatment is extremely high, a collaboration between Arkansas Children’s Hospital and Medicaid made it possible for Josephine to receive the injection — making her the first child in the state to undergo this therapy.

For her family, it was a moment filled with both hope and quiet fear.

“We held onto each other and just prayed this would help her,” Casey said. “We didn’t know what tomorrow would look like, but we knew we had to try.”

Since receiving the treatment, Josephine has begun to show small but meaningful signs of progress. Movements in her hands and legs — once absent — are slowly returning, bringing emotional moments to her family.

“The first time we saw her move again, it felt like a miracle,” her family shared. “It may seem like a small thing, but for us, it meant everything.”

Through it all, the Gilmore family has documented Josephine’s journey on their page, sharing both the challenges and the milestones. Their story reflects not only the difficulty of living with SMA, but also the deep love and resilience that carry them forward each day.

Josephine has been diagnosed with SMA type 1, the most severe form, where early treatment is especially important. While the therapy offers hope, her journey is still ongoing, and each day brings new uncertainties.

Yet, through it all, one thing remains constant — the strength of a little girl and the unwavering love of her family.

“We live in her world now,” Casey said. “And we’ll keep fighting with her, every step of the way.”